Frontier Wealth Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-27,575	Closed	-$160K	–	454
2021 Q2	$160K	Buy	27,575 +1	+0%	+$6	0.01%	413
2021 Q1	$194K	Buy	+27,574	New	+$185K	0.01%	366
2020 Q3	–	Sell	-38,874	Closed	-$262K	–	376
2020 Q2	$262K	Sell	38,874 -81,300	-68%	-$616K	0.02%	293
2020 Q1	$764K	Hold	120,174	–	–	0.12%	141
2019 Q4	$1.25M	Buy	+120,174	New	+$874K	0.2%	109
2018 Q4	–	Sell	-21,344	Closed	-$627K	–	412
2018 Q3	$627K	Sell	21,344 -6,916	-24%	-$268K	0.06%	196
2018 Q2	$1.28M	Buy	28,260 +1,175	+4%	+$57.1K	0.18%	123
2018 Q1	$1.43M	Sell	27,085 -365	-1%	-$21.3K	0.2%	117
2017 Q4	$1.87M	Buy	27,450 +4,690	+21%	+$328K	0.3%	80
2017 Q3	$1.88M	Buy	22,760 +835	+4%	+$66.2K	0.27%	96
2017 Q2	$2.05M	Sell	21,925 -275	-1%	-$16.8K	0.31%	85
2017 Q1	$1.41M	Sell	22,200 -875	-4%	-$53.2K	0.22%	117
2016 Q4	$1.02M	Sell	23,075 -17,200	-43%	-$605K	0.17%	152
2016 Q3	$1.45M	Sell	40,275 -515	-1%	-$11K	0.22%	109
2016 Q2	$560K	Sell	40,790 -14,545	-26%	-$213K	0.09%	193
2016 Q1	$1.06M	Sell	55,335 -3,860	-7%	-$81.7K	0.09%	128
2015 Q4	$2.07M	Sell	59,195 -27,700	-32%	-$1.79M	0.33%	83
2015 Q3	$7.99M	Buy	86,895 +13,550	+18%	+$1.17M	1.26%	14
2015 Q2	$6.45M	Buy	+73,345	New	+$6.28M	0.99%	19